CABERGAMOUN2TAB

Cabergamoun is a dopamine receptor agonist used primarily to treat conditions associated with high levels of prolactin in the blood. By stimulating dopamine receptors in the pituitary gland, it effectively inhibits the secretion of prolactin. It is commonly prescribed for the management of hyperprolactinemia, including prolactin-secreting adenomas, and for the inhibition of physiological lactation. This medication should only be used under strict medical supervision, as it requires careful monitoring of prolactin levels and potential side effects to ensure patient safety and therapeutic efficacy.